Trasylol & Kidney Failure ~ Missouri Lawyer ~ Attorney
Cardin & Payne Law Firm has been contacted by several patients who suffered kidney failure & strokes after open-heart surgery and wonder whether if their problems are related to having being administered Trasylol.
We are currently representing a number of people in cases involving kidney failure and other side effects. My firm is available to represent patients and their families in Trasylol kidney failure cases. Please contact David Payne if you or a loved one experienced the following:
-Had no previous history or findings associated with kidney problems
-Received Trasylol (if you don't know, we can find out for you)
-Shortly thereafter were found to have kidney damage
-Now have permanent kidney damage
Too many patients may have died due to Trasylol kidney failure. In those cases, we would represent the family of the patient and seek compensation for their loss.
Trasylol Kidney Failure (Aprotinin Kidney Failure): Study Monitored Heart Bypass Patients Given Trasylol (Aprotinin)
An article in the January 2006 issue of the New England Journal of Medicine reported on a study of 4374 heart bypass patients. 1,295 of these were administered Trasylol (aprotinin). The study found that the patients who received Trasylol (aprotinin) had significant, adverse health consequences, including the following:
-A greater death rate than the other patients in the study who were not given Trasylol (aprotinin)
-Double the risk of kidney failure (renal failure) requiring dialysis
-48% increase in the risk of myocardial infarction (heart attack)
-109% increase in the risk of heart failure
-181% increase in the risk of stroke
The study also found evidence of multi-organ damage involving the heart, brain, and kidneys. the findings of this and other Trasylol research has prompted the FDA to suspend marketing of Trasylol which results in essentially a Trasylol recall.
